The Misericordia Community Hospital is an acute care hospital located in west Edmonton, Alberta, Canada. The Misericordia is home to the Institute for Reconstructive Sciences in Medicine, a facility for reconstruction of the face, head and neck.

There are 309 beds in Misericordia Community Hospital.

During the past decade, Misericordia Community Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Misericordia Community Hospital" #1 sponsor was "University of Alberta" with 11 trials, followed by "University of Calgary" with 3 trials sponsored, "GlycoMimetics Incorporated" with 2 trials sponsored, "Edesa Biotech Inc." with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Misericordia Community Hospital" #1 collaborator was "Alberta Health services" with 3 trials as a collaborator, "Alberta Innovates Health Solutions" with 2 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "American Orthotic and Prosthetic Association" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Misericordia Community Hospital" are "COVID-19" (2 trials), "Critical Illness" (2 trials), "ARDS" (1 trials), "ARDS, Human" (1 trials) and "Acute Kidney Failure" (1 trials). Many other conditions were trialed in "Misericordia Community Hospital" in a lesser frequency.

Most popular intervention types in "Misericordia Community Hospital" are "Other" (8 trials), "Drug" (7 trials), "Device" (5 trials), "Behavioral" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Rivipansel" (2 trials), "Accelerated RRT initiation" (1 trials), "Albumin Fluid Resuscitation Optimization Intervention" (1 trials) and "Alere Triage Meter Pro" (1 trials). Other intervention names were less common.

The vast majority of trials in "Misericordia Community Hospital" are 19 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Misericordia Community Hospital". 1 are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Misericordia Community Hospital, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Misericordia Community Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".